TrialDiabetes, obesity & metabolism2020

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.

Tim Heise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.